Latest Competition News

Algorae Pharmaceuticals has locked in a $3 million revolving debt facility with ScotPac, providing flexible, non-dilutive funding to accelerate its commercial operations across Australia and New Zealand.

AdAlta Limited has aligned its AdCella manufacturing strategy with new US FDA guidelines, made a significant milestone payment to Shanghai Cell Therapy Group, and secured an additional R&D tax rebate, marking key progress in its cellular immunotherapy pipeline.

Anteris Technologies has launched a $200 million public offering alongside a $90 million strategic investment from Medtronic, aiming to accelerate its DurAVR heart valve clinical trials and manufacturing expansion.

Galileo Mining reports a robust cash position and promising exploration progress at its Norseman Project, with high-grade gold and PGE assay results expected soon. A large-scale gravity survey and a 2,000m drilling program underpin plans for an active 2026 exploration campaign.

Firebrick Pharma has introduced its Nasodine Throat Spray in Singapore, marking its first international product launch and setting the stage for further global rollouts in 2026.

Everest Metals Corporation, in partnership with Edith Cowan University, has won a $490,500 grant to accelerate its innovative rubidium extraction technology at the Mt Edon project, positioning Australia to establish its first sovereign rubidium supply.

Mercury NZ Limited reported a robust quarter with high hydro inflows driving down electricity prices and the commissioning of a new geothermal unit set to enhance generation capacity.

PhosCo Ltd reports significant progress at its Gasaat Phosphate Project in Tunisia, backed by a €1 million EBRD grant and promising drilling outcomes at KM and SAB deposits. The company is well positioned amid rising global phosphate demand and tightening supply.

Ovanti Limited has completed a $1 million capital raise through a discounted share placement to accelerate its buy now, pay later business expansion in the United States.

Neurizon Therapeutics has secured trademark protection for its NEURIZON® brand across major pharmaceutical markets, reinforcing its intellectual property strategy as it advances its lead drug candidate NUZ-001.

FBR Limited has secured a binding conditional purchase order worth AUD 990,000 from a leading US heavy equipment dealer for its Mantis welding robot, marking a significant milestone during its prototyping phase.

Critica Limited has launched a pivotal Scoping Study for its Jupiter Rare Earth Project in Western Australia, appointing Sedgman to define a capital-efficient development pathway. This marks a strategic shift from technical validation to structured economic assessment.